These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26935557)

  • 1. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Froehner M; Wirth MP
    Eur Urol; 2016 Jul; 70(1):e9. PubMed ID: 26935557
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Ost P; Ghadjar P
    Eur Urol; 2016 Jul; 70(1):e11-e12. PubMed ID: 26928380
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Blanchard P; Briganti A; Bossi A
    Eur Urol; 2016 Jul; 70(1):e15-e16. PubMed ID: 26922406
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30: Radical Prostatectomy Versus Radiation for Clinically Localized Prostate Cancer: Two Systematic Reviews and a Randomized Controlled Trial.
    Lazar AA; Lizarraga TLC; Roach M
    Eur Urol; 2016 Jul; 70(1):e13-e14. PubMed ID: 26935558
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Tree AC; van As NJ; Dearnaley DP
    Eur Urol; 2016 Jul; 70(1):e10. PubMed ID: 26948396
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Parker C
    Eur Urol; 2016 Jul; 70(1):e17. PubMed ID: 26928379
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Rano Matta, Christopher J.D. Wallis, Mitchell G. Goldenberg, et al. Variation and Trends in Antidepressant Prescribing for Men Undergoing Treatment for Nonmetastatic Prostate Cancer: A Population-based Cohort Study. Eur Urol 2019;75:3-7: Translational Potential of Dual Detection: Depression Diagnosis plus Sense of Coherence Determination in Prostate Cancer.
    Vale S
    Eur Urol; 2019 Jun; 75(6):e168-e169. PubMed ID: 30732926
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002.
    Vale C; Fisher D; Tierney J; White I; Sydes M; Carpenter J
    Eur Urol; 2018 Mar; 73(3):e49-e50. PubMed ID: 29233663
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Rano Matta, Refik Saskin, Sarah Neu, et al. Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.001.
    Rosato E; Lombardo R; Li Marzi V; Finazzi Agrò E; De Nunzio C; Albisinni S;
    Eur Urol Focus; 2023 Oct; ():. PubMed ID: 37806851
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Claire Vale, David Fisher, Jayne Tierney, Ian White, Matthew Sydes, and James Carpenter's Letter to the Editor re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002.
    Wallis CJD; Klaassen Z
    Eur Urol; 2018 Mar; 73(3):e51. PubMed ID: 29224912
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Rano Matta, Refik Saskin, Sarah Neu, et al. Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials. Eur Urol Focus 2023;9:957-65.
    Lin YH; Tsai HY; Tsao SH
    Eur Urol Focus; 2024 Mar; ():. PubMed ID: 38493068
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol 2016;69:775-87.
    Yang L; Qiu S; Wei Q
    Eur Urol; 2017 Feb; 71(2):e49-e50. PubMed ID: 27451134
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Eleonora Rosato, Riccardo Lombardo, Vincenzo Li Marzi, Enrico Finazzi Agrò, Cosimo De Nunzio, and Simone Albisinni's Letter to the Editor re: Rano Matta, Refik Saskin, Sarah Neu, et al. Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.001.
    Matta R
    Eur Urol Focus; 2023 Oct; ():. PubMed ID: 37858406
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review And Meta-analysis. Eur Urol 2019;76:284-303.
    Montorsi F; Gandaglia G; Briganti A
    Eur Urol; 2019 Nov; 76(5):e132. PubMed ID: 31400947
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Christian Bolenz, Stephen J. Freedland, Brent K. Hollenbeck, et al. costs of radical prostatectomy for prostate cancer: a systematic review. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.08.059.
    Rassweiler J
    Eur Urol; 2013 Apr; 63(4):e53-6. PubMed ID: 23312570
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Lu Yang, Shi Qiu and Qiang Wei's Letter to the Editor re: Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol 2016;69:775-87.
    Bayne CE; Williams -B; Chapin BF
    Eur Urol; 2017 Feb; 71(2):e51. PubMed ID: 27461403
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Declan G. Murphy, Christopher J. Sweeney, Bertrand Tombal. "Gotta Catch 'em All" or Do We? Pokemet Approach to Metastatic Prostate Cancer. Eur Urol 2017;72:1-3.
    Tree AC; Siva S; Ost P
    Eur Urol; 2017 Sep; 72(3):e66-e67. PubMed ID: 28642019
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Alan D. Uren, Nikki Cotterill, Christopher Harding, et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol 2017;72:402-7.
    Lee B; Kim JH
    Eur Urol; 2018 Jan; 73(1):e13-e14. PubMed ID: 28801129
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?
    Takahashi T
    Eur Urol; 2022 Jan; 81(1):e22. PubMed ID: 34716050
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA Level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol 2005;48:386-99.
    Stephan C; Schnorr D; Loening SA; Jung K
    Eur Urol; 2005 Dec; 48(6):1059-60; author reply 1060-1. PubMed ID: 16260082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.